期刊文献+

外周血T淋巴细胞亚群与不同分子分型乳腺癌患者无病生存的相关性研究 被引量:17

Effect of T-lymphocyte subpopulations in peripheral blood on disease-free survival of patients with different molecular subtypes of breast cancer
下载PDF
导出
摘要 目的:观察不同分子分型浸润性乳腺癌患者外周血T淋巴细胞亚群的表达情况,分析乳腺癌患者免疫状态与不同分子分型乳腺癌的相关性。方法:选取2008年1月至2009年8月初诊于天津医科大学肿瘤医院乳腺中心的患者372例。均对入组患者采血,采用流式细胞术分析外周血的T淋巴细胞的亚群CD4+T细胞、CD8+T细胞、调节性T细胞(Treg细胞)及自然杀伤(NK)细胞水平。分析CD4+/CD8+比值的大小、调节性T细胞、自然杀伤细胞的免疫相关指标与乳腺癌不同分子分型Luminal A、Luminal B、HER-2过表达型以及三阴性乳腺癌患者临床病理特征之间的相关性。结果:372例乳腺癌患者中,Luminal A型为133例(35.8%)、Luminal B型为124例(33.3%)、HER-2过表达型为48例(12.9%)、三阴性为67例(18.0%)。在三阴性乳腺癌中外周血CD4+/CD8+比值越高,患者的无病生存时间越长(P<0.05),Treg细胞含量越低,患者的无病生存时间也越长(P<0.05),但CD4+/CD8+比值与Treg细胞含量并非三阴性乳腺癌无病生存的独立预后因素。而其他三种类型的乳腺癌中,CD4+/CD8+比值、Treg细胞含量与患者无病生存率无关(P>0.05)。NK细胞含量与以上4种分子分型乳腺癌患者的无病生存率并无明显的相关性(P>0.05)。结论:外周血CD4+/CD8+比值、Treg细胞含量可有效预测三阴性乳腺癌的无病生存率,但并非其独立的预后因素。 Objective:To determine the distribution of T-lymphocyte subpopulations in peripheral blood and its relationship with disease-free survival (DFS) of patients with different molecular subtypes of invasive breast cancer (IBC). Methods:Data and plasma samples of 372 female patients with IBC treated at Tianjin Medical University Cancer Hospital and Institute between January 2008 and August 2009 were obtained. CD4^+/CD8^+ratio and the amount of regulatory T cells (Treg cells) and natural killer cells (NK cells) were measured through flow cytometry. Results:A total of 133 (35.8%), 124 (33.3%), 48 (12.9%), and 67 cases (18.0%) presented luminal type A, luminal type B, HER-2 over-expression, and triple-negative type breast cancer (TNBC), respectively. In TNBC, a longer DFS was observed when the peripheral CD4^+/CD8^+ratio was high or when the level of Treg cells was low (CD4^+/CD8^+P〈0.05 and Treg P〈0.05). However, CD4^+/CD8^+and Treg are not independent prognostic factors for the DFS of TNBC cases. In other molecular subtypes of breast cancer, CD4^+/CD8^+ratio and the amount of Treg cells are not correlated with DFS (P〉0.05). The level of NK cells is unrelated to the DFS of breast cancer with the four molecular subtypes (P〉0.05). Conclusion:CD4^+/CD8^+ratio and the amount of Treg cells in peripheral blood may predict DFS of TNBC but are not considered as independent prognostic factors.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2014年第21期1363-1367,共5页 Chinese Journal of Clinical Oncology
关键词 乳腺癌 外周血 免疫细胞 TREG细胞 NK细胞 breast cancer peripheral blood immune cells Treg cells NK cells
  • 相关文献

参考文献14

  • 1Siegel R,Naishadham D,Jemal A.Cancer statistics,2012[J].CA Cancer J Clin,2012,62(1):10-29.
  • 2Redig AJ,Mc Allister SS.Breast cancer as a systemic disease:a view of metastasis[J].J Intern Med,2013,274(2):113-126.
  • 3Jia Y,Xu L,Lin Q,et al.Levels of lymphocyte subsets in peripheral blood prior treatment are associated with aggressive breast cancer phenotypes or subtypes[J].Med Oncol,2014,31(6):981.
  • 4Wolff AC,Hammond ME,Schwartz JN,et al.American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer[J].Arch Pathol Lab Med,2007,131(1):18-43.
  • 5Amarante MK,Watanabe MA.The possible involvement of virus in breast cancer[J].J Cancer Res Clin Oncol,2009,135(3):329-337.
  • 6Standish LJ,Sweet ES,Novack J,et al.Breast cancer and the immune system[J].J Soc Integr Oncol,2008,6(4):158-168.
  • 7Bilik R,Mor C,Hazaz B,et al.Characterization of T-lymphocyte subpopulations infiltrating primary breast cancer[J].Cancer Immunol Immunother,1989,28(2):143-147.
  • 8陈明水,陈强,叶韵斌,李洁羽,周智峰.乳腺癌病人细胞免疫功能的变化及其意义[J].福建医药杂志,2003,25(3):18-20. 被引量:6
  • 9Xiao T,Kagami S,Saeki H,et al.Both IL-4 and IL-13 inhibit the TNF-alpha and IFN-gamma enhanced MDC production in a human keratinocyte cell line,Ha CaT cells[J].J Dermatol Sci,2003,31(2):111-117.
  • 10Hermann C,Assmus B,Urbich C,et al.Insulin-mediated stimulation of protein kinase Akt:A potent survival signaling cascade for endothelial cells[J].Arterioscler Thromb Vasc Biol,2000,20(2):402-409.

二级参考文献21

  • 1刘莉,丁乾,曹如波,王晶,姚军霞,黄士昂.恶性肿瘤患者外周血CD4^+ CD25^+调节T细胞的检测及其临床意义[J].临床肿瘤学杂志,2005,10(4):342-345. 被引量:16
  • 2赵守华 ,刘向阳 ,谢清军 .老年肿瘤病人的特殊性及其处理对策[J].中国医刊,2005,40(9):19-21. 被引量:3
  • 3刘向阳.恶性肿瘤转移与复发的外科治疗[J].中国医刊,2007,42(6):2-3. 被引量:1
  • 4Liyanaga UK, Moore Tr, Joo HG, et al. Prevalence of regulatory T ceils is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma [J]. J Immunol, 2002, 169: 2756-2761.
  • 5Liu W, Putnam A L, Xu -Yu Z, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4 + Treg cells.[J]. Exp Med, 2006, 203: 1701-1711.
  • 6Trzonkowski P, Szmit E, Mysliwska J et al. CD4+ CD25+ T regulatory cells inhibit cytotoxic activity of CTL and NK cells in humansimpact of immunosenescence [J ]. Clin Immunol, 2006, 119: 307- 316.
  • 7Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self- tolerance maintained by activated T ceils expressing IL-2 receptor alpha-chains (CD25) . Breakdown of a single mechanism of self-tolerance causes various autoimmunc diseases [J]. J Immunol, 1995, 155 (3): 1151-1164.
  • 8Seddiki N, Santner - Nanan B, Martinson J, et al. Expression of interleukin IL -2 and IL-7 receptors discriminates between human regulatory and activated T cells[J]. J ExpMed, 2006, 203: 1693- 1700.
  • 9Hartigan - O'Connor D J, Poon C, Sinclair E, et al. Human CD4 (+) regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells[J]. Immunol Methods, 2007, 319: 41-52.
  • 10Wolf AM, Wolf D, SteurerM, et al. Increase of regulatory T cells in the peripheral blood of cancer patients [J]. Clin Cancer Res, 2003, 9 (2): 606-612.

共引文献12

同被引文献130

引证文献17

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部